Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells.

[1]  D. Davis,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors , 2011, Journal of Virology.

[2]  P. Kellam,et al.  X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein–Barr virus in co-infected primary effusion lymphoma , 2011, The Journal of general virology.

[3]  T. Sata,et al.  A novel real‐time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses , 2010, Journal of medical virology.

[4]  D. Dittmer,et al.  Toll-like receptor signaling controls reactivation of KSHV from latency , 2009, Proceedings of the National Academy of Sciences.

[5]  O. Tokunaga,et al.  Fumagillin inhibits colorectal cancer growth and metastasis in mice: In vivo and in vitro study of anti‐angiogenesis , 2009, Pathology international.

[6]  G. Tosato,et al.  Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma , 2009, Leukemia.

[7]  S. Chanda,et al.  Systematic Identification of Cellular Signals Reactivating Kaposi Sarcoma–Associated Herpesvirus , 2007, PLoS pathogens.

[8]  S. Kenney.  Human Herpesviruses: Reactivation and lytic replication of EBV , 2007 .

[9]  D. Lukac,et al.  Reactivation and lytic replication of EBV , 2007 .

[10]  P. Moore,et al.  Reactivation and lytic replication of KSHV -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis , 2007 .

[11]  T. Sata,et al.  Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction with poly(A)-binding protein. , 2006, Virology.

[12]  P. Lieberman,et al.  Acetylation of the Latency-Associated Nuclear Antigen Regulates Repression of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription , 2006, Journal of Virology.

[13]  C. D. Thompson,et al.  A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non–Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo , 2006, Clinical Cancer Research.

[14]  T. Sata,et al.  Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases. , 2006, The Journal of infectious diseases.

[15]  M. Offermann,et al.  Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. , 2004, The Journal of general virology.

[16]  Li‐Wha Wu,et al.  Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence. , 2004, Biochemical pharmacology.

[17]  C. D. Thompson,et al.  A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Corbellino,et al.  Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Crews,et al.  The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Mori,et al.  Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. , 2000, Virology.

[21]  Y. Chang,et al.  Kaposi's sarcoma. , 2000, The New England journal of medicine.

[22]  T. Kawarabayashi,et al.  TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro. , 2000, Anticancer research.

[23]  S. Sakurada,et al.  Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS‐associated Kaposi's sarcoma , 1999, Journal of medical virology.

[24]  H. Satoh,et al.  Establishing and characterizing a CD30‐positive cell line harboring HHV‐8 from a primary effusion lymphoma , 1999, Journal of medical virology.

[25]  S. Mori,et al.  High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. , 1999, The American journal of pathology.

[26]  E. Jaffe,et al.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.

[27]  Eric C. Griffith,et al.  Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Widom,et al.  Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.

[29]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. V. Von Roenn,et al.  Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus. , 1997, Advances in cancer research.

[32]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[34]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[35]  D. Ingber,et al.  Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.

[36]  D. Marmé,et al.  AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. , 1992, Biochemical and biophysical research communications.

[37]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.